Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Teladoc Started at Buy by Guggenheim as Healthcare Access Moves Digital

Published 2022-04-07, 10:12 a/m
© Reuters.
TDOC
-

By Sam Boughedda

Investing.com -- Teladoc Inc (NYSE:TDOC) shares gained in early Thursday trading after Guggenheim initiated a Buy rating on the company's shares. 

Analyst Sandy Draper set a price target of $96, telling investors in a note that they believe "healthcare access is moving more toward digital interactions, and TDOC’s broad suite of services addresses more touch points than any other provider."

Teladoc shares surged during the pandemic as lockdowns forced people to utilize telehealth services. However, they have since fallen to pre-pandemic levels. 

Draper acknowledged the pandemic caused a short-term upswing in awareness and utilization, but added that it has also accelerated the longer-term shift to broad-based adoption.

"Over the last 12 months, the stock has been under pressure over concerns of a post-COVID slowdown in utilization and slower expected future membership growth," wrote the analyst.

"We believe that growth in revenue per customer will offset slowing membership growth, and TDOC will be able to deliver 25-30% revenue growth through 2024 and 20+ % growth longer term."

Teladoc shares climbed 2.8% Thursday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.